Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $15.4M |
| Sales growthchange from the year before | +53.4% |
| Operating marginshare of sales left after running the business | -1971.6% |
| Net marginshare of sales kept as profit | -1800.6% |
| Free-cash-flow marginspare cash generated per $100 of sales | -1536.1% |
| Return on invested capitalprofit made on each $100 put into the business | -42.2% |
| Return on equityprofit vs. shareholders' accounting value | -48.8% |
3 insiders sold $83K on the open market.
| Bergstrom Donald APresident, R&D | SoldJul 28 | 2,237 shat $18.61 · $42K |
| Rahmer PeterSee remarks | SoldJul 28 | 748 shat $18.61 · $14K |
| Catinazzo ThomasChief Financial Officer | SoldJul 28 | 1,459 shat $18.61 · $27K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy